Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Watchlisten für Ihre Werte
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

NEURONETICS, INC.

(STIM)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über NEURONETICS, INC.
10.01.Health Care Stocks Return to Positive Ground This Afternoon
10.01.Neuronetics Preliminary Q4 Revenue Tops Street Estimates; Shares Climb
10.01.NEURONETICS : Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results - ..
10.01.Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results
10.01.NeuroStar Advanced Therapy for Mental Health Recognized as Top Neuromodulation Solution..
10.01.Neuronetics, Inc. Updates Earnings Guidance for the Fourth Quarter and Full Year of 202..
2021Neuronetics Says MT Cap Technology for NeuroStar Advanced Therapy for Mental Health Cle..
2021Neuronetics Announces 510(k) Clearance of MT Cap Technology for NeuroStar® Advanced The..
2021Neuronetics, Inc. Announces 510(k) Clearance of MT Cap Technology for NeuroStar Advance..
2021Neuronetics Announces Key Role for NeuroStar Advanced Therapy at 4th International Brai..
2021Neuronetics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conferen..
2021NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Resu..
2021Neuronetics, Inc. Revises Financial Guidance for the Year 2021
2021Neuronetics, Inc. Supplemental Financial and Operating Information
2021STIM Corporate Presentation November 2021
2021NEURONETICS : Q3 Earnings Snapshot
2021Neuronetics Reports Third Quarter 2021 Financial and Operating Results - Form 8-K
2021Earnings Flash (STIM) NEURONETICS Posts Q3 Revenue $13.8M, vs. Street Est of $13.9M
2021Neuronetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended ..
2021NEURONETICS, INC. : Regulation FD Disclosure (form 8-K)
2021Neuronetics Reports Third Quarter 2021 Financial and Operating Results
2021Neuronetics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 202..
2021Neuronetics to Supply Transcranial Magnetic Stimulation Equipment to River Region Psych..
2021Neuronetics and River Region Psychiatry Announce Exclusive Partnership
2021Neuronetics, Inc. Enters into Exclusive Supplier of Transcranial Magnetic Stimulation E..
2021Neuronetics Celebrates 235,000 Treatment Milestone for Success TMS
2021Neuronetics to Report Third Quarter 2021 Financial and Operating Results and Host Confe..
2021NEURONETICS : Press Release, dated October 20, 2021, of Neuronetics, Inc - Form 8-K/A
2021NEURONETICS : CORRECTION - Neuronetics Announces Preliminary Revenue for Third Quarter 202..
2021NEURONETICS : Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health
2021Neuronetics Launches Upgrades of NeuroStar? Advanced Therapy for Mental Health
2021THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of Neuronetics, Inc. (STIM) on ..
2021NORTH AMERICAN MORNING BRIEFING : Investors to -3-
2021AFTER HOURS WATCH LIST SCORECARD : Vst, stim, rgls
2021Health Care Stocks Edging Higher Ahead of Wednesday Close
2021Health Care Stocks Finding Increased Support This Afternoon
2021Wall Street Wavers Pre-Bell as US Consumer Prices Rise More Than Expected, Fed Minutes ..
2021Top Premarket Decliners
2021NEURONETICS : Cuts Q3 Sales Guidance -- Shares Plummet in Premarket Trading
2021MT NEWSWIRES AFTER HOURS WATCH LIST : Vst, stim, rgls
2021NEURONETICS : Cuts Q3 Sales Guidance, Shares Slump 20% After Hours
2021NEURONETICS : Press Release, dated October 12, 2021, of Neuronetics Inc - Form 8-K
2021NEURONETICS : Lowers Q3 Revenue Guidance
2021NEURONETICS : Announces Preliminary Revenue for Third Quarter 2021
2021Neuronetics, Inc. Revises Revenue Guidance for the Third Quarter of 2021
2021Neuronetics, Inc. Provides Revenue Guidance for the Year 2021
2021NEURONETICS : Grants Success TMS Exclusive Use of Its NeuroStar Platform for Treatment-Res..
2021NEURONETICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and E..
2021NEURONETICS : Announces Commercial Agreement with Success TMS
2021Neuronetics, Inc. Enters into Exclusive, Five-Year Commercial Agreement with Success TM..
2021NEURONETICS : NeuroStar® Advanced Therapy Recognizes National Depression Education and Awa..
2021NEURONETICS : STIM Corporate Presentation October 2021
2021UPDATE - New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over ..
2021Health Care Stocks Holding Onto Gains in Late Trade
2021NEURONETICS : Says Transcranial Magnetic Stimulation Treatment Showed 'Significantly Lower..
2021NEURONETICS : New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Ove..
2021Neuronetics, Inc Announces New Data Highlights NeuroStar® Advanced Therapy for Mental H..
2021NEURONETICS, INC.(NASDAQGM : STIM) added to S&P Global BMI Index
2021Neuronetics and Zion Healing Announce First Franchise Model for TMS Clinics
2021Neuronetics and Zion Healing Announces First Franchise Model for TMS Clinics
2021NEURONETICS : STIM Corporate Presentation August 2021
2021NEURONETICS : Launches New Website to Meet Patient Demand for Depression Resources
2021NEURONETICS, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, F..
2021NEURONETICS : Announces Appointment of Megan Rosengarten to its Board of Directors
2021Neuronetics Announces Appointment of Megan Rosengarten to Its Board of Directors
2021NEURONETICS : Management's Discussion and Analysis of Financial Condition and Results of O..
2021NEURONETICS : Smaller Q2 Loss, Higher Revenue Trail Street Estimates; Stock Slumps Nearly ..
2021NEURONETICS : Q2 Earnings Snapshot
2021NEURONETICS : Supplemental Financial and Operating Information
2021NEURONETICS : STIM Corporate Presentation August 2021
2021NEURONETICS, INC. : Regulation FD Disclosure (form 8-K)
2021NEURONETICS : Reports Second Quarter 2021 Financial and Operating Results (Form 8-K)
2021NEURONETICS : Earnings Flash (STIM) NEURONETICS Reports Q2 Revenue $14.2M, vs. Street Est ..
2021Neuronetics Reports Second Quarter 2021 Financial and Operating Results
2021Neuronetics, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2021
1  2  3  4  5Weiter
Anstehende Termine für NEURONETICS, INC.